Virginia J. Sanders, PhD

VP, Preclinical Development
DIMERx, Inc.
Mill Valley, California

Disclosure information not submitted.

Presentation(s):

• Novel, Non-Addictive Opioid Dimer DMX-101 Targets Peripheral Opioid Receptors for Treatment of Chronic Pain without Risks Associated with Traditional Opioids

  POSTER ABSTRACT